PRIX GALIEN JAPAN
Japan to host its first Prix Galien: the gold comes to Tokyo in 2027
Prix Galien Japan Awards Categories
Best Pharmaceutical Product
Best Biotechnology Product
Best Orphan and Rare Disease Product
Best Medical Technology
Best Digital Health Solution
Best Startup (Biotech & Medtech/Digital Health)
“My heartfelt congratulations on the launch of the Prix Galien in Japan. This award recognizes that the cumulative efforts of long-term research generate value for society and carry forward the progress and integrity of science into the future.”
- Prof. Tasuku Honjo, Nobel Laureate
“Through international collaboration, innovation in medicine advances hope and transforms lives worldwide. The launch of the Prix Galien Japan embodies this spirit.”
- Prof. Shinya Yamanaka, Nobel Laureate
Japan is an extraordinary contributor to life sciences research globally, preceeded only by the United States and China, and second only to the United States in branded medicines. Japan’s deeply scientific innovation agenda is focused on some of the most consequential frontiers in global health, from oncology and regenerative medicine to AI-enabled drug discovery, digital health, and advanced therapeutic platforms. With a culture celebrating precision, and the relentless pursuit of progress, its mature industrial fabric and scale backed by a national strategy to build a ¥100 trillion bioeconomy by 2030, Japan is the country to watch for biopharmaceutical innovation.
Prix Galien Japan Judging Committee
A prestigious committee comprising some of the finest distinguished researchers in their fields will be chaired by Professor Takashi Kadowaki, President of the Japanese Association of Medical Sciences. The committee will judge submissions to the inaugural prize in the categories: Best Pharmaceutical Product, Best Biotechnology Product, Best Orphan and Rare Disease Product, Best Medical Technology, Best Digital Health Solution, and Best Startup.



